David J Holland1, Peter A Simos2, Jang Yoon2, Pirathaban Sivabalan2, Jaineel Ramnarain2, Naomi J Runnegar3. 1. Princess Alexandra Hospital, Brisbane, Qld, Australia; Department of Cardiology, Sunshine Coast University Hospital, Brisbane, Qld, Australia; School of Human Movement and Nutrition Studies, The University of Queensland, Brisbane, Qld, Australia. Electronic address: d.holland@uq.edu.au. 2. Princess Alexandra Hospital, Brisbane, Qld, Australia. 3. Princess Alexandra Hospital, Brisbane, Qld, Australia; School of Medicine, The University of Queensland, Brisbane, Qld, Australia.
Abstract
BACKGROUND: The epidemiology of infective endocarditis (IE) continues to evolve, with antimicrobial resistance and clinical outcomes largely dependent on the environment of acquisition. This study aimed to provide a contemporary review of the microbiology and antimicrobial management of IE and report echocardiographic findings and predictors of adverse outcomes in community-acquired and health care-associated IE. METHODS: Consecutive presentations of IE to a major Australian tertiary referral centre between January 2011 and April 2016 were examined. Culprit organisms and resistance patterns were recorded, as was transthoracic and transoesophageal echocardiography. Real-world antimicrobial prescription and use of an outpatient parenteral antimicrobial therapy (OPAT) service were also assessed, and clinical outcomes analysed. RESULTS: Of 204 consecutive cases, 30% were associated with health care, a group with a higher burden of comorbidities and more prone to complications. Health care-associated cases had lower rates of surgical intervention but higher mortality. A history of intravenous drug use (IVDU) conferred risk for recurrent IE whereas multivalvular involvement predicted heart failure hospitalisation. Staphylococcus aureus was isolated in 45%. Whilst methicillin resistance remains low, the prevalence of S. aureus IE is increasing. Single antimicrobial agents were commonly used (83%) and therapy via OPAT was safe and significantly reduced length of hospital stay. Not undergoing transoesophageal echocardiography (TOE) or definitive surgical management conferred poorer prognosis. CONCLUSIONS: The epidemiology of IE is evolving and there is need for updated epidemiological data and associated clinical outcomes. Environment of acquisition remains important in the face of increasing health care provision and the changing predominance of culprit microorganisms. Crown
BACKGROUND: The epidemiology of infective endocarditis (IE) continues to evolve, with antimicrobial resistance and clinical outcomes largely dependent on the environment of acquisition. This study aimed to provide a contemporary review of the microbiology and antimicrobial management of IE and report echocardiographic findings and predictors of adverse outcomes in community-acquired and health care-associated IE. METHODS: Consecutive presentations of IE to a major Australian tertiary referral centre between January 2011 and April 2016 were examined. Culprit organisms and resistance patterns were recorded, as was transthoracic and transoesophageal echocardiography. Real-world antimicrobial prescription and use of an outpatient parenteral antimicrobial therapy (OPAT) service were also assessed, and clinical outcomes analysed. RESULTS: Of 204 consecutive cases, 30% were associated with health care, a group with a higher burden of comorbidities and more prone to complications. Health care-associated cases had lower rates of surgical intervention but higher mortality. A history of intravenous drug use (IVDU) conferred risk for recurrent IE whereas multivalvular involvement predicted heart failure hospitalisation. Staphylococcus aureus was isolated in 45%. Whilst methicillin resistance remains low, the prevalence of S. aureus IE is increasing. Single antimicrobial agents were commonly used (83%) and therapy via OPAT was safe and significantly reduced length of hospital stay. Not undergoing transoesophageal echocardiography (TOE) or definitive surgical management conferred poorer prognosis. CONCLUSIONS: The epidemiology of IE is evolving and there is need for updated epidemiological data and associated clinical outcomes. Environment of acquisition remains important in the face of increasing health care provision and the changing predominance of culprit microorganisms. Crown
Authors: Ruchi Bhandari; Shabnam Tiwari; Talia Alexander; Frank H Annie; Umar Kaleem; Affan Irfan; Sudarshan Balla; R Constance Wiener; Chris Cook; Aravinda Nanjundappa; Mark Bates; Ellen Thompson; Gordon S Smith; Judith Feinberg; Melanie A Fisher Journal: J Clin Med Date: 2022-06-18 Impact factor: 4.964
Authors: Quincy A Hathaway; Aneri B Balar; Taylor A Mallicoat; Jeffery A Voss; Md Shahrier Amin; Dhairya A Lakhani; Cathy Kim Journal: Radiol Case Rep Date: 2022-09-07
Authors: Sara Álvarez-Zaballos; Victor González-Ramallo; Eduard Quintana; Patricia Muñoz; Sofía de la Villa-Martínez; M Carmen Fariñas; Francisco Arnáiz-de Las Revillas; Arístides de Alarcón; M Ángeles Rodríguez-Esteban; José M Miró; Miguel Angel Goenaga; Josune Goikoetxea-Agirre; Elisa García-Vázquez; Lucía Boix-Palop; Manuel Martínez-Sellés Journal: J Clin Med Date: 2022-08-13 Impact factor: 4.964